Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Hall

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 14, 2006
1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists: Structure-activity relationships of 4- and 5-substituted benzoic acid derivativesAdrian Hall, Susan H Brown, Iain P Chessell, et al.
Bioorganic & Medicinal Chemistry Letters|December 19, 2006
1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists. Structure-activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivativesAdrian Hall, Susan H Brown, Iain P Chessell, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2007
Identification of novel glycine sulfonamide antagonists for the EP1 receptorStephen C McKeown, Adrian Hall, Richard Blunt, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2006
Structure-activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonistsAdrian Hall, Stephen Atkinson, Susan H Brown, et al.
Bioorganic & Medicinal Chemistry Letters|November 5, 2015
Identification and optimisation of a series of tetrahydrobenzotriazoles as metabotropic glutamate receptor 5-selective positive allosteric modulators that improve performance in a preclinical model of cognitionJohn M Ellard, Andrew Madin, Oliver Philps, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2006
The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory painGerard M P Giblin, Rino A Bit, Susan H Brown, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2006
Discovery of novel biaryl heterocyclic EP1 receptor antagonistsAdrian Hall, Rino A Bit, Susan H Brown, et al.
Neuropharmacology|March 15, 2013
Orally bioavailable and brain-penetrant pyridazine and pyridine-derived γ-secretase modulators reduced amyloidogenic Aβ peptides in vivoYunhong Huang, Ting Li, Andrew Eatherton, et al.
Bioorganic & Medicinal Chemistry Letters|June 4, 2011
Pyridazine-derived γ-secretase modulatorsZehong Wan, Adrian Hall, Yun Jin, et al.
Chemmedchem|June 5, 2023
European Medicinal Chemistry Leaders in Industry (EMCL) - On the Status and Future of Medicinal Chemistry Research in EuropeAmjad Ali, Marcus Bauser, Sophie Bertrand, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|November 14, 2006
1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists: Structure-activity relationships of 4- and 5-substituted benzoic acid derivativesAdrian Hall, Susan H Brown, Iain P Chessell, et al.
Bioorganic & Medicinal Chemistry Letters|December 19, 2006
1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists. Structure-activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivativesAdrian Hall, Susan H Brown, Iain P Chessell, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2007
Identification of novel glycine sulfonamide antagonists for the EP1 receptorStephen C McKeown, Adrian Hall, Richard Blunt, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2006
Structure-activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonistsAdrian Hall, Stephen Atkinson, Susan H Brown, et al.
Bioorganic & Medicinal Chemistry Letters|November 5, 2015
Identification and optimisation of a series of tetrahydrobenzotriazoles as metabotropic glutamate receptor 5-selective positive allosteric modulators that improve performance in a preclinical model of cognitionJohn M Ellard, Andrew Madin, Oliver Philps, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2006
The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory painGerard M P Giblin, Rino A Bit, Susan H Brown, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2006
Discovery of novel biaryl heterocyclic EP1 receptor antagonistsAdrian Hall, Rino A Bit, Susan H Brown, et al.
Neuropharmacology|March 15, 2013
Orally bioavailable and brain-penetrant pyridazine and pyridine-derived γ-secretase modulators reduced amyloidogenic Aβ peptides in vivoYunhong Huang, Ting Li, Andrew Eatherton, et al.
Bioorganic & Medicinal Chemistry Letters|June 4, 2011
Pyridazine-derived γ-secretase modulatorsZehong Wan, Adrian Hall, Yun Jin, et al.
Chemmedchem|June 5, 2023
European Medicinal Chemistry Leaders in Industry (EMCL) - On the Status and Future of Medicinal Chemistry Research in EuropeAmjad Ali, Marcus Bauser, Sophie Bertrand, et al.
Pageof 8